TW200716124A - Penciclovir for the treatment of recurrent genital herpes with a one-day application - Google Patents

Penciclovir for the treatment of recurrent genital herpes with a one-day application

Info

Publication number
TW200716124A
TW200716124A TW095110943A TW95110943A TW200716124A TW 200716124 A TW200716124 A TW 200716124A TW 095110943 A TW095110943 A TW 095110943A TW 95110943 A TW95110943 A TW 95110943A TW 200716124 A TW200716124 A TW 200716124A
Authority
TW
Taiwan
Prior art keywords
treatment
penciclovir
genital herpes
recurrent genital
day application
Prior art date
Application number
TW095110943A
Other languages
English (en)
Inventor
Stephan Billstein
Robert Charnas
Spotswood L Spruance
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200716124A publication Critical patent/TW200716124A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW095110943A 2005-03-30 2006-03-29 Penciclovir for the treatment of recurrent genital herpes with a one-day application TW200716124A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66653605P 2005-03-30 2005-03-30

Publications (1)

Publication Number Publication Date
TW200716124A true TW200716124A (en) 2007-05-01

Family

ID=36829888

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095110943A TW200716124A (en) 2005-03-30 2006-03-29 Penciclovir for the treatment of recurrent genital herpes with a one-day application

Country Status (15)

Country Link
US (4) US20100298353A1 (zh)
EP (2) EP1865961B1 (zh)
JP (3) JP2008534603A (zh)
KR (1) KR101312820B1 (zh)
CN (1) CN101678028A (zh)
AT (1) ATE545419T1 (zh)
AU (3) AU2006230269A1 (zh)
BR (1) BRPI0609793A2 (zh)
CA (1) CA2602641A1 (zh)
ES (1) ES2382664T3 (zh)
PL (1) PL1865961T3 (zh)
PT (1) PT1865961E (zh)
RU (2) RU2007139762A (zh)
TW (1) TW200716124A (zh)
WO (1) WO2006105194A2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
DE3671227D1 (de) 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Also Published As

Publication number Publication date
KR101312820B1 (ko) 2013-09-27
PL1865961T3 (pl) 2012-07-31
ATE545419T1 (de) 2012-03-15
RU2432951C2 (ru) 2011-11-10
WO2006105194A3 (en) 2006-12-21
RU2007139762A (ru) 2009-05-10
BRPI0609793A2 (pt) 2010-04-27
AU2010201834B2 (en) 2012-04-19
RU2007139758A (ru) 2009-05-10
PT1865961E (pt) 2012-05-22
JP2013049687A (ja) 2013-03-14
ES2382664T3 (es) 2012-06-12
JP6018473B2 (ja) 2016-11-02
EP1865961A1 (en) 2007-12-19
US20150005324A1 (en) 2015-01-01
AU2006230291A1 (en) 2006-10-05
EP2363131A1 (en) 2011-09-07
AU2006230269A1 (en) 2006-10-05
US20120329814A1 (en) 2012-12-27
JP2008534603A (ja) 2008-08-28
AU2010201834A1 (en) 2010-05-27
CA2602641A1 (en) 2006-10-05
CN101678028A (zh) 2010-03-24
US20120088781A1 (en) 2012-04-12
KR20080004535A (ko) 2008-01-09
WO2006105194A2 (en) 2006-10-05
JP2015163614A (ja) 2015-09-10
AU2006230291A8 (en) 2013-10-24
US20100298353A1 (en) 2010-11-25
EP1865961B1 (en) 2012-02-15

Similar Documents

Publication Publication Date Title
TNSN05234A1 (en) Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor
CL2010000188A1 (es) Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso.
UY27720A1 (es) Aroilpiridinonas monocíclicas,
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
PL1755661T3 (pl) Gelsolina do stosowania w leczeniu infekcji
MX2007015958A (es) Composiciones de peptido lkktet y/o lkktnt, y metodos.
MX2008016453A (es) Composiciones y metodos para tratar infecciones parasitas.
UY29459A1 (es) Forma cristalina ortorrómbica del maleato de asenapina y su uso en el tratamiento de trastornos mentales
MX2009004696A (es) Uso de 3-alfa-androestandiol, opcionalmente en combinacion con un inhibidor pde5, en el tratamiento de disfuncion sexual.
WO2008043052A3 (en) Human antibodies neutralizing human metapneumovirus
BR0306820A (pt) Uso de inibidores cox-2 em combinação com agentes antivirais para o tratamento de infecções de papilomavìrus
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
SI2185561T1 (sl) Derivati 1,2,3,4-tetrahidropirolo(1,2-alfa)pirazin-6-karboksamidov in 2,3,4,5-tetrahidropirolo(1,2-alfa)-diazepin-7-karboksamidov, njihova priprava in njihova terapevtska uporaba
EP1660010A4 (en) COMPOSITIONS AND METHODS FOR RE-ESTABLISHING SENSITIVITY TO ANTAGONIST TREATMENT OF HER2
WO2007109093A3 (en) Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
WO2005077356A3 (en) Glycine and/or for use in cartilage affecting conditions
TW200716124A (en) Penciclovir for the treatment of recurrent genital herpes with a one-day application
BRPI0408500A (pt) tratamento do diabetes do tipo 1 com inibidores de pde5
UY29532A1 (es) Derivados del ácido 6,7-dihidro-5h-imidazo(1,2-a)imidazol-3-sulfónico
SI1658062T1 (sl) Alfa aminoamidni derivati uporabni kot protivnetna sredstva
WO2006083949A3 (en) Sepsis prevention through adenosine receptor modulation
WO2006121865A3 (en) Methods of treating recurrent aphthous stomatitis
WO2007117289A3 (en) Methods for treating or preventing erectile dysfunction or urinary incontinence
WO2007062048A3 (en) Role of proteoglycans in drug dependence